Arsenic Trioxide in Combination with All-Trans Retinoic Acid for the Treatment of Newly Diagnosed Patients with High-Risk APL By Ogkologos - September 3, 2025 440 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the APOLLO study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR Five Questions With…Linda. April 7, 2022 Does Living Near Power Lines Increase My Risk of Cancer? March 17, 2022 Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients... December 2, 2024 Pancancer Activity of Dabrafenib Plus Trametinib in Patients with BRAFV600E-Mutated Rare... April 24, 2023 Load more HOT NEWS Good News and Cautions about Pregnancy for Childhood Cancer Survivors 4-Year-Old Secretly Told Teacher His Dad Was Sick, And She Donated... Understanding FDA Emergency Use Authorization For Children with Neuroblastoma, Trial Results Highlight Continued Evolution of Treatment
